Beth Onners

2.3k total citations
16 papers, 1.2k citations indexed

About

Beth Onners is a scholar working on Oncology, Immunology and Biotechnology. According to data from OpenAlex, Beth Onners has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Immunology and 7 papers in Biotechnology. Recurrent topics in Beth Onners's work include Immunotherapy and Immune Responses (11 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer Research and Treatments (7 papers). Beth Onners is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer Research and Treatments (7 papers). Beth Onners collaborates with scholars based in United States and China. Beth Onners's co-authors include Elizabeth M. Jaffee, Dung T. Le, Elizabeth A. Sugar, Sara Solt, Eric R. Lutz, Daniel A. Laheru, Jennifer N. Uram, Dan Laheru, Irena Tartakovsky and Barbara Biedrzycki and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and Clinical Cancer Research.

In The Last Decade

Beth Onners

16 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beth Onners United States 10 1.1k 761 175 117 113 16 1.2k
Mona Møller Norway 7 588 0.5× 525 0.7× 364 2.1× 102 0.9× 139 1.2× 7 964
Irena Tartakovsky United States 5 526 0.5× 397 0.5× 95 0.5× 47 0.4× 65 0.6× 6 610
Sissel Trachsel Norway 8 412 0.4× 335 0.4× 311 1.8× 121 1.0× 115 1.0× 8 732
Marie Christine Wulff Westergaard Denmark 16 602 0.6× 482 0.6× 178 1.0× 75 0.6× 23 0.2× 24 831
Hannah Dada United States 2 666 0.6× 588 0.8× 206 1.2× 89 0.8× 19 0.2× 2 892
Hideo Komita Japan 17 408 0.4× 446 0.6× 199 1.1× 40 0.3× 39 0.3× 27 650
Samantha Bucktrout United States 10 821 0.8× 710 0.9× 285 1.6× 132 1.1× 14 0.1× 14 1.1k
Carol DePriest United States 17 587 0.5× 573 0.8× 180 1.0× 38 0.3× 41 0.4× 38 755
Karin M. Knudson United States 15 489 0.4× 502 0.7× 196 1.1× 57 0.5× 25 0.2× 24 807
Yasuko Tada Japan 6 877 0.8× 691 0.9× 167 1.0× 103 0.9× 20 0.2× 8 1.2k

Countries citing papers authored by Beth Onners

Since Specialization
Citations

This map shows the geographic impact of Beth Onners's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Onners with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Onners more than expected).

Fields of papers citing papers by Beth Onners

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Onners. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Onners. The network helps show where Beth Onners may publish in the future.

Co-authorship network of co-authors of Beth Onners

This figure shows the co-authorship network connecting the top 25 collaborators of Beth Onners. A scholar is included among the top collaborators of Beth Onners based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth Onners. Beth Onners is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Lee, Valerie, Ding Ding, Beth Onners, et al.. (2021). A phase 2 study of cyclophosphamide (CY), GVAX, pembrolizumab (Pembro), and stereotactic body radiation (SBRT) in patients (pts) with locally advanced pancreas cancer (LAPC).. Journal of Clinical Oncology. 39(15_suppl). 4134–4134. 10 indexed citations
3.
Wu, Annie A., Katherine M. Bever, Won Jin Ho, et al.. (2020). A Phase II Study of Allogeneic GM-CSF–Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer. Clinical Cancer Research. 26(19). 5129–5139. 91 indexed citations
4.
Hacker‐Prietz, Amy, et al.. (2019). Oncology Couples’ Retreats: A Focus on Relationships Between Patients and Their Caregivers. Journal of the Advanced Practitioner in Oncology. 10(7). 702–709. 1 indexed citations
5.
Herman, Joseph M., Rose Parkinson, Beth Onners, et al.. (2015). Preliminary Results of a Pilot Study Evaluating An Allogeneic GM-CSF Pancreatic Tumor Cell Vaccine (GVAX) and Cytoxan (Cy) With Stereotactic Body Radiation Therapy (SBRT) and Folfirinox (FFX) in Patients With Resected Pancreatic Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 93(3). S154–S154. 1 indexed citations
6.
Le, Dung T., Andrea Wang‐Gillam, Vincent J. Picozzi, et al.. (2014). A phase 2, randomized trial of GVAX pancreas and CRS-207 immunotherapy versus GVAX alone in patients with metastatic pancreatic adenocarcinoma: Updated results.. Journal of Clinical Oncology. 32(3_suppl). 177–177. 25 indexed citations
7.
8.
Patel, Rina K, Andrew H. Ko, Beth Onners, et al.. (2014). A phase 2, multicenter study of FOLFIRINOX followed by ipilimumab in combination with allogeneic GM-CSF transfected pancreatic tumor vaccine in the treatment of metastatic pancreatic cancer.. Journal of Clinical Oncology. 32(15_suppl). TPS4160–TPS4160. 6 indexed citations
9.
Le, Dung T., Eric R. Lutz, Jennifer N. Uram, et al.. (2013). Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer. Journal of Immunotherapy. 36(7). 382–389. 437 indexed citations
10.
Le, Dung T., Andrea Wang‐Gillam, Vincent J. Picozzi, et al.. (2013). Interim safety and efficacy analysis of a phase II, randomized study of GVAX pancreas and CRS-207 immunotherapy in patients with metastatic pancreatic cancer.. Journal of Clinical Oncology. 31(15_suppl). 4040–4040. 9 indexed citations
11.
Le, Dung T., Eric R. Lutz, Lanqing Huang, et al.. (2012). Phase Ib study of ipilimumab alone or in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene (vaccine) in pancreatic cancer.. Journal of Clinical Oncology. 30(4_suppl). 211–211. 4 indexed citations
12.
Yeo, Charles J., Keith D. Lillemoe, Barbara Biedrzycki, et al.. (2011). A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma. Annals of Surgery. 253(2). 328–335. 295 indexed citations
13.
14.
Laheru, Dan, Charles J. Yeo, Barbara Biedrzycki, et al.. (2007). A safety and efficacy trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene in combination with adjuvant chemoradiotherapy for the treatment of adenocarcinoma of the pancreas. Journal of Clinical Oncology. 25(18_suppl). 3010–3010. 15 indexed citations
15.
16.
Shelton, Brenda K., et al.. (1996). Bone Marrow Transplantation. AACN Clinical Issues Advanced Practice in Acute & Critical Care. 7(1). 95–108. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona Møller Breakdown of academic impact, for papers by Irena Tartakovsky Breakdown of academic impact, for papers by Sissel Trachsel Breakdown of academic impact, for papers by Marie Christine Wulff Westergaard Breakdown of academic impact, for papers by Hannah Dada Breakdown of academic impact, for papers by Hideo Komita Breakdown of academic impact, for papers by Samantha Bucktrout Breakdown of academic impact, for papers by Carol DePriest Breakdown of academic impact, for papers by Karin M. Knudson Breakdown of academic impact, for papers by Yasuko Tada
Rankless by CCL
2026